PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2020

Radioprotective Activity of the Nitric Oxide Synthase Inhibitor T1023. Toxicological and Biochemical Properties, Cardiovascular and Radioprotective Effects.

Mixed / Radiation

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 34609510 ↗2020Reported benefit

Radioprotective Activity of the Nitric Oxide Synthase Inhibitor T1023. Toxicological and Biochemical Properties, Cardiovascular and Radioprotective Effects.

MixedRadiationWistar rats (mouse strain not stated)MaleIntraperitonealLD10 317 mg/kg and LD50 410 mg/kg in mice; radioprotective…Prophylactic, 5 to 120 minutes before total-body irradiation

Model: Total-body irradiation causing haematopoietic and gastrointestinal acute radiation syndrome

T1023 acted as a hypoxic radioprotector with a dose modifying factor of 1.6 to 1.9, reducing early bone marrow devastation by about 40%, lessening maximal neutropenia and thrombocytopenia 2 to 2.5 fold and shortening recovery time by 30 to 40%, but only when given before irradiation.

Extraction: extract · Supplied extraction confidence: 0.75. Machine-extracted fields require source verification.